eCFR Reference Browser

---

title: "21 CFR §821.20"

source: "https://www.ecfr.gov/current/title-21/section-821.20"

title_number: "21"

volume_number: "8"

chapter_number: "Unknown"

subchapter_code: "H"

subchapter_subject: "MEDICAL DEVICES"

part_code: "821"

part_subject: "MEDICAL DEVICE TRACKING REQUIREMENTS"

subpart_code: "B"

subpart_subject: "Tracking Requirements"

section_number: "821.20"

section_subject: "Devices subject to tracking."

cfr_reference: "21 CFR 821.20"

title_name: "Title 21"

title_subject: "Food and Drugs"

parts_covered: "Parts 800 to 1299"

revised_date: "Revised as of April 1, 2019"

publication_date: "As of April 1, 2019"

contains_description: "Containing a codification of documents of general applicability and future effect"

publication_info: "Published by the Office of the Federal Register National Archives and Records Administration as a Special Edition of the Federal Register"

---

(a)A manufacturer of any class II or class III device that fits within one of the three criteria within § 821.1(a) must track that device in accordance with this part, if FDA issues a tracking order to that manufacturer.

(b)When responding to premarket notification submissions and premarket approval applications, FDA will notify the sponsor by issuing an order that states that FDA believes the device meets the criteria of section 519(e)(1) of the act and, by virtue of the order, the sponsor must track the device.

§821.20 - Devices subject to tracking.